Search for: "Lupin Pharmaceuticals"
Results 1 - 20
of 175
Sort by Relevance
|
Sort by Date
18 Jan 2024, 9:16 am
Additionally, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
14 Jan 2024, 9:29 pm
Lupin Ltd. [read post]
7 Jan 2024, 9:59 pm
Lupin Ltd. [read post]
2 Jan 2024, 8:45 pm
Lupin Ltd. [read post]
18 Dec 2023, 9:07 pm
Lupin Ltd. [read post]
11 Dec 2023, 7:43 am
Lupin Ltd. the Federal Circuit “somewhat controversially” states that: [S]ubstantial noninfringing use in section 271(c) refers to uses that do not infringe the patent in question, not other patents. [read post]
7 Dec 2023, 1:47 pm
Lupin Ltd., Nos. 2022-1194, 2022-1208, 2022-1246 (Fed. [read post]
13 Jun 2022, 6:00 am
Irbesartan is manufactured by Lupin Pharmaceuticals Inc., and has been on the market since 1997. [read post]
26 Oct 2021, 8:03 am
The FDA and Lupin Pharmaceuticals recently announced a voluntary recall for certain blood-pressure tablets because they might contain cancer-causing ingredients. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
30 Jan 2020, 10:49 am
Lupin Limited – Texas – $63 million. [read post]
24 Jan 2020, 10:24 am
Lupin – In November 2019, pharmaceutical manufacturer Lupin Limited and related entities, as well as company executives, agreed to pay $63 million to resolve claims brought by a whistleblower under the Texas Medicaid Fraud Prevention Act that Lupin reported inflated drug prices to the state’s Medicaid program in order to receive excess reimbursements Greenway Health – In February 2019, Greenway Health LLC, an electronic health records vendor,… [read post]
30 Apr 2019, 3:24 am
May 30, 2019 - 1 PM: Lupin Pharmaceuticals, Inc. v. [read post]
1 Jun 2018, 7:21 am
" Endo Pharmaceuticals Inc. v. [read post]
7 Dec 2017, 9:34 pm
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
., and Acrux DDS Pty Ltd. had filed a patent infringement lawsuit in the Southern District of Indiana alleging that Defendants, Perrigo Company, Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have… [read post]
6 May 2017, 10:11 am
Lupin, Ltd., 676 F.3d 1316,1321 (Fed. [read post]
25 Jan 2017, 11:25 pm
However, claim 27 is to “a pharmaceutical composition comprising a compound according to any one of claims 1-25 together with a pharmaceutically acceptable carrier and optionally other therapeutic ingredients” (emphasis added). [read post]
4 Sep 2016, 9:13 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
28 Aug 2016, 6:00 am
Horizon Pharma filed an action for patent infringement against Actavis and Lupin Pharmaceuticals in response to the filing of Abbreviated New Drug Applications (ANDAs) by both defendants for a generic version of Pennsaid, a topical nonsteroidal anti-inflammatory drug (NSAID) marketed in the U.S. by Horizon. [read post]
